Literature DB >> 15547771

Pathology of human metapneumovirus infection: insights into the pathogenesis of a newly identified respiratory virus.

Sara O Vargas1, Harry P W Kozakewich, Antonio R Perez-Atayde, Alexander J McAdam.   

Abstract

Human metapneumovirus (hMPV) is a recently discovered human virus that causes significant respiratory infections. Pathologic features of hMPV infection have not been described. A total of 1257 pediatric respiratory samples submitted for routine clinical virologic testing were additionally tested for hMPV by reverse transcriptase polymerase chain reaction (PCR). Pathology specimens, available in 6 of 53 hMPV-positive patients, were examined by light and electron microscopy and included 6 bronchoalveolar lavage (BAL) and 3 lung biopsy specimens from 6 patients (3 girls and 3 boys) ranging in age from 1 to 16 years. BAL from three patients performed within 4 days of the positive hMPV assay showed epithelial degenerative changes and eosinophilic cytoplasmic inclusions within epithelial cells, multinucleate giant cells, and histiocytes. Inclusions were not seen in three patients with BAL performed = 1 month from the time of their positive assay. Lung biopsy, performed in three patients, all = 1 month from the time of their positive assay, showed chronic airway inflammation and intraalveolar foamy and hemosiderin-laden macrophages; all three patients had an underlying pulmonary/systemic disorder. Our findings delineate the clinicopathologic features in hMPV-infected patients undergoing anatomic sampling, which may provide diagnostic guidance to a practicing pathologist. Further, they contribute toward understanding the pathogenesis of hMPV infection.

Entities:  

Mesh:

Year:  2004        PMID: 15547771     DOI: 10.1007/s10024-004-1011-2

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  19 in total

1.  Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats.

Authors:  Marie-Eve Hamelin; Kevin Yim; Katie H Kuhn; Rose P Cragin; Marina Boukhvalova; Jorge C G Blanco; Gregory A Prince; Guy Boivin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 2.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

3.  A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.

Authors:  Jennifer E Schuster; Reagan G Cox; Andrew K Hastings; Kelli L Boyd; Jay Wadia; Zhifeng Chen; Dennis R Burton; R Anthony Williamson; John V Williams
Journal:  J Infect Dis       Date:  2014-05-26       Impact factor: 5.226

Review 4.  To assemble or not to assemble: The changing rules of pneumovirus transmission.

Authors:  Nicolás Cifuentes-Muñoz; Rebecca Ellis Dutch
Journal:  Virus Res       Date:  2019-03-05       Impact factor: 3.303

Review 5.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

6.  Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.

Authors:  J Tyler Kinder; Carole L Moncman; Chelsea Barrett; Hong Jin; Nicole Kallewaard; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

7.  Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.

Authors:  Céline Deffrasnes; Marie-Eve Hamelin; Gregory A Prince; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

8.  Burden of human metapneumovirus infection in young children.

Authors:  Kathryn M Edwards; Yuwei Zhu; Marie R Griffin; Geoffrey A Weinberg; Caroline B Hall; Peter G Szilagyi; Mary A Staat; Marika Iwane; Mila M Prill; John V Williams
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

9.  Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model.

Authors:  Laetitia Aerts; Marie-Ève Hamelin; Chantal Rhéaume; Sophie Lavigne; Christian Couture; Woojin Kim; Delia Susan-Resiga; Annik Prat; Nabil G Seidah; Nathalie Vergnolle; Beatrice Riteau; Guy Boivin
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

10.  Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice.

Authors:  Jorge A Soto; Nicolás M S Gálvez; Gaspar A Pacheco; Gisela Canedo-Marroquín; Susan M Bueno; Alexis M Kalergis
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.